Brain Metastasis in Breast Cancer Patients

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this epidemiologic study is to establish a population-based cohort of women with advanced stage breast cancer which can be used to quantify the frequency and timing of brain metastases, and other distant metastases, in this patient population.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Lapatinib; Trastuzumab

Criteria

Inclusion Criteria:

• Initially diagnosed with American Joint Commission on Cancer (AJCC) stage III or stage IV breast cancer between January 1, 1995 through December 31, 2007 -OR- diagnosed with AJCC stage I or II breast cancer and progressed to stage III or IV disease between January 1, 1995 through December 31, 2007;

• At least one year of follow-up after initial diagnosis (among patients who did not die before one year of follow-up); and

• Age 30 years or older at diagnosis.

Exclusion Criteria:

• Does not have at least one year of follow-up after initial diagnosis (among patients who did not die before one year of follow-up); and

• Age less than 30 years or older at diagnosis.